Time in tight range and time in range for predicting the achievement of typical glucose management indicator and HbA1c targets-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Time in tight range and time in range for predicting the achievement of typical glucose management indicator and HbA1c targets

Published:2025-05-07 Issue:8 Volume:68 Page:1674-1679
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Kim Seohyun,Park Sang Ho,Lee Jin A.,Cho So Hyun,Oh Rosa,Kim Ji Yoon,Lee You-Bin,Kim Gyuri,Hur Kyu Yeon,Kim Jae Hyeon,Jin Sang-Man

Funder

the Bio&Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00125-025-06442-2.pdf

Reference11 articles.

1. Lu J, Ma X, Zhou J et al (2018) Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes. Diabetes Care 41(11):2370–2376. https://doi.org/10.2337/dc18-1131

2. Yoo JH, Choi MS, Ahn J et al (2020) Association between continuous glucose monitoring-derived time in range, other core metrics, and albuminuria in type 2 diabetes. Diabetes Technol Ther 22(10):768–776. https://doi.org/10.1089/dia.2019.0499

3. Foreman YD, van Doorn W, Schaper NC et al (2021) Greater daily glucose variability and lower time in range assessed with continuous glucose monitoring are associated with greater aortic stiffness: The Maastricht Study. Diabetologia 64(8):1880–1892. https://doi.org/10.1007/s00125-021-05474-8

4. Steck AK, Dong F, Taki I et al (2019) Continuous glucose monitoring predicts progression to diabetes in autoantibody positive children. J Clin Endocrinol Metab 104(8):3337–3344. https://doi.org/10.1210/jc.2018-02196

5. Battelino T, Bergenstal RM, Rodríguez A et al (2022) Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial. Lancet Diabetes Endocrinol 10(6):407–417. https://doi.org/10.1016/s2213-8587(22)00077-8

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations of time in tight range, time in range, and glycated hemoglobin with albuminuria in type 1 diabetes: A cross-sectional study;Diabetes Research and Clinical Practice;2025-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.7亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2025 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3